STAT+: Recent pharma-telehealth partnerships feel ‘black boxy,’ and why that’s problematic

STAT March 26, 2025
Katie Palmer

The drugmaker deals call for research on possible unnecessary prescriptions and subpar care, health policy experts say

In recent months, a new kind of partnership between telehealth companies and pharmaceutical manufacturers has come under scrutiny over concerns that such arrangements could lead to inappropriate prescriptions and poor care. Eli Lilly and Pfizer, along with five telehealth companies accessible through the pharma companies’ websites, have recently received letters from four senators echoing those concerns, asking questions about care, prescription volume, and the flow of data and...

Today's Sponsors

Today's Sponsor